CSL Innovation - Research and Clinical Bioanalytics


Research and Clinical Bioanalytics

Accreditation No.


Site No.


Date of Accreditation

12 Aug 2016


Bio21 Institute, Nancy Millis Building, Level 4, 30 Flemington Road
University Of Melbourne, VIC 3010



Dr Megan Barnden P: +61 (03) 93896769


Services not available to external clients

Scope of Recognition

ISO/IEC 17025 (2017) and the OECD GLP Principles (1997) interpreted for research (2)

  • The OECD Council Decision on the Mutual Acceptance of Data is not applicable to this work.

Healthcare, Pharmaceutical and Media Products

Service Product Determinant Technique Procedure
Conduct of research into candidate biologic therapeutics Animal biological samples - Clinical trials; Animal biological samples - Pre-clinical studies; Human biological samples - Clinical trials; Human biological samples - Pre-clinical studies Anti-drug antibodies measurement; Drug and/or biological agents concentrations Enzyme linked immunosorbent assay (ELISA) - Electrochemiluminescence (ECL); Flow cytometry - Cell phenotyping, receptor occupancy assay; LC-MS-MS; Multiplex assays

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.